Utilizing Small Molecule Inhibitors and Oral Therapeutic...

added blog Health

2026-01-02 12:23:22 -

Utilizing Small Molecule Inhibitors and Oral Therapeutic Alternatives within the Asthma and COPD Drugs Sector for Late 2025

While inhalers remain the primary delivery method, the quest for effective "oral" alternatives for asthma and COPD has reached a critical milestone in late 2025. New small molecule inhibitors, such as phosphodiesterase-4 (PDE4) and Janus kinase (JAK) inhibitors, are being developed to provide systemic anti-inflammatory effects without the broad side effects of traditional oral steroids. These...

0 Comments 0 Shares 83 Views 0 Reviews